These findings suggest that novel molecular mechanisms of GLUT3 for the EMT process act via the TGF-β/JNK/ATF2 pathway, thereby exacerbating the invasive ability of cancer cells in metastatic colorectal cancer (Figure 7). Here, ATF2 is linked to metastatic colorectal cancer.